বঙ্গবন্ধু শেখ মুজিব মেডিকেল বিশ্ববিদ্যালয় পিজি হাসপাতাল নামেই বেশি পরিচিত বাংলাদেশের প্রথম চিকিৎসা বিশ্ববিদ্যালয়। বিশ্ববিদ্যালয় হওয়ার আগে এর নাম ছিল ইন্সটিটিউট অফ পোস্ট গ্রাজুয়েট মেডিসিন এন্ড রিসার্চ।

During the past decade, Bangabandhu Sheikh Mujib Medical University conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 1 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bangabandhu Sheikh Mujib Medical University" #1 sponsor was "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh" with 36 trials, followed by "Globe Pharmaceuticals Limited" with 2 trials sponsored, "Thayyil, Sudhin" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "D16 Pharma & Biotec Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bangabandhu Sheikh Mujib Medical University" #1 collaborator was "Dhaka Medical College" with 3 trials as a collaborator, "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh" with 2 trials as a collaborator, "Anwar Khan Mordern Medical College and Hospital, Dhaka" with 1 trials as a collaborator, "Bangladesh College Of Physicians And Surgeons (BCPS)" with 1 trials as a collaborator and "Bangladesh Reference Institute of Chemical Measurements (BRICM)" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Bangabandhu Sheikh Mujib Medical University" are "Covid19" (3 trials), "MDD" (2 trials), "OCD" (2 trials), "ASD" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Bangabandhu Sheikh Mujib Medical University" in a lesser frequency.

Most popular intervention types in "Bangabandhu Sheikh Mujib Medical University" are "Drug" (29 trials), "Dietary Supplement" (7 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vitamin D3" (3 trials), "Placebo oral capsule" (2 trials), "0.9% normal saline" (1 trials) and "2d speckle tracking echocardiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bangabandhu Sheikh Mujib Medical University" are 39 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Bangabandhu Sheikh Mujib Medical University". 1 are not yet recruiting, 10 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Bangabandhu Sheikh Mujib Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bangabandhu Sheikh Mujib Medical University, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 12 trials that are defined as “Not Applicable".

Bangabandhu Sheikh Mujib Medical University has several departments that took part in Clinical trials: "Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University" - 4 trials, "Basic Science and Paraclinical Science of BSMMU" - 2 trials